Epicure Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
Epicure Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. It has received 1 NIH small-business research grant, $1.5 million in total.
Profile compiled from public records. Is this your company? Request a correction or update
Epicure Therapeutics at a glance
Typebiotechnology company
HeadquartersSeattle, Washington, United States
What does Epicure Therapeutics do?
US government research funding
1 NIH small-business research grant, $1.5 million in total. NIH funding came from the National Institute of Neurological Disorders and Stroke.
Frequently asked questions about Epicure Therapeutics
Where is Epicure Therapeutics headquartered?
Epicure Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Epicure Therapeutics do?
Epicure Therapeutics, Inc. is a biotechnology company.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences